AML1-ETO downregulates the granulocytic differentiation factor C/EBPalpha in t(8;21) myeloid leukemia. (Q38302335)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11283671%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

AML1-ETO downregulates the granulocytic differentiation factor C/EBPalpha in t(8;21) myeloid leukemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11283671%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11283671%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

Pabst T

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11283671%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Mueller BU

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11283671%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Harakawa N

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11283671%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Schoch C

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11283671%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Haferlach T

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11283671%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Behre G

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11283671%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Hiddemann W

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11283671%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Zhang DE

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11283671%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

language of work or name

English

0 references

publication date

1 April 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11283671%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11283671%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11283671%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

444-451

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11283671%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11283671%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/86515

6 November 2019

exact match

0 references

cites work

Tissue-specific expression, developmental regulation, and genetic mapping of the gene encoding CCAAT/enhancer binding protein.

1 reference

7 January 2021

Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells

1 reference

7 January 2021

Increased hepatic cell proliferation and lung abnormalities in mice deficient in CCAAT/enhancer binding protein alpha

1 reference

7 January 2021

Cell lineage-specific and differentiation-dependent patterns of CCAAT/enhancer binding protein alpha expression in the gut epithelium of normal and transgenic mice

1 reference

7 January 2021

Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein alpha-deficient mice

1 reference

7 January 2021

CCAAT/enhancer binding protein alpha is a regulatory switch sufficient for induction of granulocytic development from bipotential myeloid progenitors

1 reference

7 January 2021

Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia

1 reference

7 January 2021

Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia

1 reference

7 January 2021

AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis

1 reference

7 January 2021

t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1

1 reference

7 January 2021

PEBP2/CBF, the murine homolog of the human myeloid AML1 and PEBP2 beta/CBF beta proto-oncoproteins, regulates the murine myeloperoxidase and neutrophil elastase genes in immature myeloid cells

1 reference

7 January 2021

CCAAT enhancer-binding protein (C/EBP) and AML1 (CBF alpha2) synergistically activate the macrophage colony-stimulating factor receptor promoter

1 reference

7 January 2021

Multiple functional domains of AML1: PU.1 and C/EBPalpha synergize with different regions of AML1

1 reference

7 January 2021

Identification of a region which directs the monocytic activity of the colony-stimulating factor 1 (macrophage colony-stimulating factor) receptor promoter and binds PEBP2/CBF (AML1)

1 reference

7 January 2021

Synergistic up-regulation of the myeloid-specific promoter for the macrophage colony-stimulating factor receptor by AML1 and the t(8;21) fusion protein may contribute to leukemogenesis

1 reference

7 January 2021

Embryonic lethality and impairment of haematopoiesis in mice heterozygous for an AML1-ETO fusion gene.

1 reference

7 January 2021

The AML1/ETO fusion protein activates transcription of BCL-2

1 reference

7 January 2021

The t(8;21) fusion protein, AML1/ETO, transforms NIH3T3 cells and activates AP-1.

1 reference

7 January 2021

The t(8;21) fusion protein interferes with AML-1B-dependent transcriptional activation

1 reference

7 January 2021

The t(8;21) fusion product, AML-1-ETO, associates with C/EBP-alpha, inhibits C/EBP-alpha-dependent transcription, and blocks granulocytic differentiation

1 reference

7 January 2021

Establishment and characterization of a human histiocytic lymphoma cell line (U-937)

1 reference

7 January 2021

Autoregulation of the human C/EBP alpha gene by stimulation of upstream stimulatory factor binding

1 reference

7 January 2021

CCAAT/enhancer binding protein gene promoter: binding of nuclear factors during differentiation of 3T3-L1 preadipocytes

1 reference

7 January 2021

High level activity of the mouse CCAAT/enhancer binding protein (C/EBP alpha) gene promoter involves autoregulation and several ubiquitous transcription factors

1 reference

7 January 2021

Chromosomal translocations in human cancer.

1 reference

7 January 2021

AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation

1 reference

7 January 2021

Repressive effect of Sp1 on the C/EBPalpha gene promoter: role in adipocyte differentiation

1 reference

7 January 2021

Derepression of the C/EBPalpha gene during adipogenesis: identification of AP-2alpha as a repressor

1 reference

7 January 2021

A novel function for Myc: inhibition of C/EBP-dependent gene activation

1 reference

7 January 2021

Comparative detection and quantitation of human CDK inhibitor mRNA expression of p15INK4B, p16INK4A, p16beta, p18INK4C, p19INK4D, p21WAF1, p27KIP1 and p57KIP2 by RT-PCR using a polycompetitive internal standard

1 reference

7 January 2021

Tight control of gene expression in mammalian cells by tetracycline-responsive promoters

1 reference

7 January 2021

Identifiers

DOI

10.1038/86515

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11283671%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference